"一般診療、および、治験（臨床試験）を実施する施設です。"

During the past decade, Tokyo center clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tokyo center clinic" are "Dyslipidemias" (2 trials), "Covid19" (1 trials), "Psoriasis" (1 trials), "Psoriasis Arthropatica" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Tokyo center clinic" in a lesser frequency.

Most popular intervention types in "Tokyo center clinic" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (1 trials), "K-237 0.3-0.4mg/kg (once daily)" (1 trials), "K-877 ER 0.2 mg/day (once daily)" (1 trials), "K-877 ER 0.2 mg/day evening administration (once daily)" (1 trials) and "K-877 ER 0.2 mg/day morning administration (once daily)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo center clinic" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo center clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tokyo center clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo center clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".